Nanobiotechnology

Martin Ntwaeaborwa is a professor of physics at the University of the Free State in Bloemfontein-South Africa. He has published more than 190 articles and has given numerous invited talks at local and international conferences. He is the director of UNESCO-TWAS centre of excellence for advancement of science in developing countries.

Nanotechnogy

Gerd Kaupp has completed his PhD at the age of 24 years from Würzburg University and postdoctoral studies from Iowa State, Lausanne, and Freiburg University. He held a full-professorship till 2005 in Oldenburg, Germany, and he privately continues his research on AFM on rough surfaces (since 1988), the as yet better resolving sub-diffraction limit microscopy also for non-fluorescing materials, even rough ones, of all types (resolution <10 nm, since 1995), and nano-indentations (since 2000). He has published more than 300 papers in renowned journals and has been serving as an editorial board member of several scientific journals.

Physics of nanosized mechanics and local detection

Werner Lottermoser has completed his thesis work about neutron diffraction and magnetism of special silicates from Francfort University (Germany) and university lecturing qualification on Single Crystal Mössbauer Spectroscopy (SCMBS) in 1996 from Salzburg University (Austria). He is now working on sub-nanometric imaging, nanomaterials and materials for industrial applications. He has published more than 65 papers in reputed journals and 150 abstracts and has been serving e.g. for one year as a referee board member at the Journal of Physical Chemistry A. Recently, he was awarded the Austrian Staatspreis for Innovation together with AB-Microelectronics, Salzburg

sub-nanometric imaging, nanomaterials and materials for industrial applications

Gerd Kaupp has completed his PhD at the age of 24 years from Würzburg University and postdoctoral studies from Iowa State, Lausanne, and Freiburg University. He held a full-professorship till 2005 in Oldenburg, Germany, and he privately continues his research on AFM on rough surfaces (since 1988), the as yet better resolving sub-diffraction limit microscopy also for non-fluorescing materials, even rough ones, of all types (resolution <10 nm, since 1995), and nano-indentations (since 2000). He has published more than 300 papers in renowned journals and has been serving as an editorial board member of several scientific journals.

Physics of nanosized mechanics and local detection

Werner Lottermoser has completed his thesis work about neutron diffraction and magnetism of special silicates from Francfort University (Germany) and university lecturing qualification on Single Crystal Mössbauer Spectroscopy (SCMBS) in 1996 from Salzburg University (Austria). He is now working on sub-nanometric imaging, nanomaterials and materials for industrial applications. He has published more than 65 papers in reputed journals and 150 abstracts and has been serving e.g. for one year as a referee board member at the Journal of Physical Chemistry A. Recently, he was awarded the Austrian Staatspreis for Innovation together with AB-Microelectronics, Salzburg

sub-nanometric imaging, nanomaterials and materials for industrial applications

Martin Ntwaeaborwa is a professor of physics at the University of the Free State in Bloemfontein-South Africa. He has published more than 190 articles and has given numerous invited talks at local and international conferences. He is the director of UNESCO-TWAS centre of excellence for advancement of science in developing countries.

Nanotechnogy

Dr. Fenniri was educated at the University of Louis Pasteur in Strasbourg, France, receiving his undergraduate degree in chemistry and biochemistry (1989, top of his class), and his M.Sc./Ph.D. degrees in supramolecular science and engineering (1990/1994) under the supervision of Professor Jean-Marie Lehn (Nobel Laureate). He then joined the Scripps Research Institute in California, USA, where he carried out his postdoctoral training under the supervision of Professor Richard A. Lerner (President and CEO). In 1997 he moved to Purdue University, where he initiated his independent academic career, and established the Purdue Laboratory for Chemical Nanotechnology (1999). In 2003, He joined the National Research Council and the University of Alberta to build and lead the Supramolecular Nanoscale Assembly program, and contribute to the shaping of the National Institute for Nanotechnology (NINT), its research programs and facilities, and the recruitment of highly qualified personnel. NINT has since grown from 4 principal investigators in 2003 to a vibrant research and technology organization of over 350 researchers in 2013. In addition, Dr. Fenniri held a full professor position with the Department of Chemistry (since 2003-2013) and adjunct full professor positions with the department of biomedical engineering (since 2010) with the faculty of medicine, and with the department if Chemistry (since 2013) at the University of Alberta. Dr. Fenniri is currently Professor Chemical and Biomedical Engineering at Northeastern University, Boston, MA, USA. Dr. Fenniri has achieved international recognition as a leader in the areas of self-assembly, supramolecular chemistry, nanomedicine, combinatorial chemistry, and materials sciences. His group works at the forefront of basic and applied nanosciences, in collaboration with various academic institutions, federal laboratories, and with the private sector. Dr. Fenniri’s contributions appeared in over 190 publications, 8 patents, and over 400 contributed national and international conference papers. Dr. Fenniri has also presented his work in over 150 invited distinguished lectures, colloquia and seminars around the globe. His research programs are supported by the Natural Science and Engineering Research Council of Canada, Alberta Advanced Education and Technology, the US National Institutes of Health, the National Research Council of Canada, the University of Alberta, and several private, provincial and federal funding organizations. Dr. Fenniri is the recipient of several academic and professional honours and awards, including the Xerox UAC Award (2006–2008), the 3M Faculty Award (2000, 2002), the Showalter Trust Fund Award (1999, 2001), the Trask Trust Fund Technology Innovation Award (2000), the Cottrell Teacher Scholar Award (2000–2005), and the US National Science Foundation Career Award (1999–2003). Dr. Fenniri is Member of the Editorial Board of several scientific journals and serves on several national and international scientific boards, panels, and committees. Dr. Fenniri has been an invited professor at the Université de Strasbourg and the Collège de France (2010), the National University of Taiwan (2007), and the University of Colorado Boulder, USA (2004). He has also been DAAD Visiting Professor at Regensburg University, Germany (2002, 2003).

Cell and Molecular biology (Cloning, protein expression and purification, signaling) Microbiology (Clinical isolation and related study, antimicrobial testing nano-formulations) Microfluidic chip applications for research and diagnosis (Surface Plasmon based binding assay and diagnostics)

Dr Antony is an Associate Professor at the School of Chemical and Process Engineering, University of Leeds. His primary research interest is in the area of Particulate Mechanics and Physics, especially on the bulk behaviour of powders and grain under industrial process conditions as a function of particle-scale properties. He performs a number of inter-disciplinary research projects including in the area of biomechanics. He uses wide range of computational tools such as DEM, FEM, theoretical and experimental procedures in his research. He has obtained the prestigious MIT Young Researcher Fellowship Award for Exemplary Research in Computational Mechanics. He has made several publications in reputed international journals and conference proceedings. He serves as a member of editorial boards for many international journals in his filed including Journal of Nanotechnology and Research Letters in Nano Technology. Also, he serves as a regular referee for several international journals, including Physical Review Letters and Physical Review E. He has served as a guest editor for the Jl. Granular Matter and the lead editor of the book ‘Granular Materials: Fundamentals and Applications’, published by the Royal Society of Chemistry, London in 2004. He is a member of many professional bodies worldwide. His research sponsors include EPSRC, Royal Society, DTI, ICI, BNFL, P&G, Pfizer, Borax Hosakawa Micron, Bridon International Ltd, Merck Sharp & Dohme, DuPont and Kayser-Threde. His biography is included in the Edition of Marquis Who's Who in the World and the Directory of International Biography Centre, Cambridge.

Multiscale Modelling and Experiments. Nano Mechanics, Micro Mechanics, Granular Materials and Powder Technology. Mechanics of Space Materials and Design of Space Exploration Devices. Sensing Stresses in Human Eye. Building Structures from Wastes. Diversity in Engineering and Inter-disciplinary Research

Shaker A Mousa finished his PhD from Ohio State University, College of Medicine, Columbus, OH and Post-doctoral Fellowship, University of Kentucky, Lexington KY. He also received his MBA from Widener University, Chester, PA. He is currently an endowed tenure Professor and Executive Vice President and Chairman of the Pharmaceutical Research Institute and Vice Provost for Research at ACPHS. Prior to his academic career, he was a senior Scientist and fellow at The DuPont Pharmaceutical Company for 17 years, where he contributed to the discovery and development of several FDA approved and globally marketed diagnostics and therapeutics. He holds over 350 US and International Patents discovering novel anti-angiogenesis strategies, antithrombotics, anti-integrins, anti-cancer, and non-invasive diagnostic imaging approaches employing various nanotechnology platforms. His has published more than 1,000 journal articles, book chapters, published patents, and books as editor and author. He is a member of several NIH study sections, and the Editorial Board Member of several high impact Journals. His research has focused on diagnostics and therapeutics of angiogenesis-related disorders, thrombosis, vascular and cardiovascular diseases.

Dr. Mousa's current research interests include: Adhesion molecules in health and diseases, Novel therapeutic and diagnostic targets, Treatment and prevention of ischemic and coronary artery diseases, Angiogenesis modulation, vascular and tissue remodeling, and novel anti-platelet, anti-thrombotic and anti-ischemic therapies. Dr. Mousa received a Ph.D. in Pharmacology from The Ohio State University, completed postdoctoral research in Cardiovascular Pharmacology at the University of Kentucky and earned his MBA from Widener University. A native of Alexandria, Egypt, he received his B.Pharm. and M.Sc. degrees from Alexandria University. He was elected a fellow of the American College of Cardiology (FACC) and a fellow of the National Academy of Clinical Biochemistry (FACB), and is a member of several national and international societies. He was recently awarded grants through the U.S. Department of Defense and the National Institute of Health.

Dr. Nadia Benkirane is Research director and head of the “ Osteoarticular and Dental regenerative Nanomedicine” laboratory, at INSERM (French National Institute for Health and Medical Research), UMR 1109, Strasbourg, France. She was leader of “Active Biomaterials and Tissue Engineering” team INSERM 977. She received her Ph.D. from University Louis Pasteur, ULP, Strasbourg, France for the work on Development of pseudopeptides as synthetic vaccines. Dr. Jessel (Benkirane) then held a postdoctoral position in collaboration with the Institut Pasteur, Paris, France, working on Immunotherapy HIV, and another postdoctoral position on the application of modified peptides as vaccines against FMDV (Plum Island Animal Disease Center, ARS, USDA, Greenport, NY 11944-0848, USA). She joined the INSERM U595 in 2002 as a post-doc, and received the diploma to direct the research (HDR) in 2004. Dr. Jessel got the permanent position (CR1) in the INSERM 595 laboratory in 2004 and Research Director (DR2) position in the INSERM 977 and head of “active Biomaterials and Tissue Engineering team from 2009 until 2012). Currently Research Director (DR1) in the INSERM UMR 1109 (Osteoarticular and Dental Regenerative Nanomedicine" and heads the team. Dr. Jessel possesses expertise in diverse fields of molecular and cellular biology, immunochemistry, tissue engineering and biomedical engineering. In the last 10 years, she focused her research on the bio-functionalization of multilayered polyelectrolyte architectures with emphasis on the use of these architectures to induce specific cellular responses and gain control over cell proliferation and differentiation. Dr. Benkirane-Jessel have 138 publications (h index: 36) with peer-reviewed publications in high impact factor journals (Proc. Nat. Acad. Sci. USA; Adv. Mater.; Adv. Funct. Mater.; Small; Nanoletters, Biomaterials, ACS Nano), 5 chapters reviews and 5 international patents, she is a regular referee for a number of scientific journals (Nature nanotechnology, Nature Materials, ACS nano, Biomaterials, Nanoletters…). She is under the contract (Interface INSERM/Clinic 2008-2013) and she got also “Prime d’Excellence Scientifique” from the INSERM, 2010-2014 and the PEDR from the INSERM on 2016 for 4 years.

Molecular and cellular biology, immunochemistry, tissue engineering and biomedical engineering. In the last 10 years, she focused her research on the bio-functionalization of multilayered polyelectrolyte architectures with emphasis on the use of these architectures to induce specific cellular responses and gain control over cell proliferation and differentiation.

Luis Ulloa, PhD., is Associate Professor at the department of Surgery at the New Jersey Medical School in the Rutgers University. He is also a member of the Center for Immunity and Inflammation. Dr Ulloa has made significant contributions to science. Dr Ulloa was among the original investigators describing the Smad in the TGF signaling and their crosstalk with other immune signals such as the Interferon. This mechanism is now proposed to be critical in embryogenesis, oncogenesis and inflammatory bowel disorders. Dr Ulloa was among the original investigators describing the anti-inflammatory potential of the vagus nerve, and its potential to control systemic inflammation in experimental trauma and sepsis. Dr Ulloa gor his first NIH grant as a pioner studying the immunological role of classical neurotransmitter and their signalling pathway controlling immune cells. Dr Ulloa published over 70 peer-review international articles in the most prestiguous journals with over 13,000 total citations. Dr Ulloa has received numerous scientific awards such as the International Human Frontier Fellowship, the Rutgers University ‘Excellence in Research’ Award and the National Scientist Development Award of the American Heart Association. He is invited to write editorials and review articles in journals like Nature Reviews and Trends in Mol Med. His studies are funded by department of Defense, American Heart Association, and the NIH.

Immunology, Allergy, Cell signalling, Neuroimmunology, Rheumatology